Cyclobenzaprine Hydrochloride
- Product NDC
- 71335-2156
- 11-digit product format
- 713352156
- Labeler code
- 71335
- Product ID
- 71335-2156_959dab21-96f5-44a0-a405-0343eeb428b5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA078643
- Marketing category
- ANDA
- Marketing start
- 2008-09-26
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclobenzaprine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0VE05JYS2P |
| Rxcui | 828320 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-2156-0 | Cyclobenzaprine Hydrochloride | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 105 |
| 71335-2156-1 | Cyclobenzaprine Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 105 |
| 71335-2156-2 | Cyclobenzaprine Hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 105 |
| 71335-2156-3 | Cyclobenzaprine Hydrochloride | 21 in 1 BOTTLE | TABLET, FILM COATED | 21 | | 105 |
| 71335-2156-4 | Cyclobenzaprine Hydrochloride | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | | 105 |
| 71335-2156-5 | Cyclobenzaprine Hydrochloride | 15 in 1 BOTTLE | TABLET, FILM COATED | 15 | | 105 |
| 71335-2156-6 | Cyclobenzaprine Hydrochloride | 40 in 1 BOTTLE | TABLET, FILM COATED | 40 | | 105 |
| 71335-2156-7 | Cyclobenzaprine Hydrochloride | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 105 |
| 71335-2156-8 | Cyclobenzaprine Hydrochloride | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | | 105 |
| 71335-2156-9 | Cyclobenzaprine Hydrochloride | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | | 105 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-2156 | CYCLOBENZAPRINE HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK] | 105 | Current NDC, Legacy NDC, 10 package rows | 20240823_0a695685-cfec-464e-840c-32e3b7a68bd3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-2156-0 | 71335215600 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-2156-0) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-1 | 71335215601 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2156-1) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-2 | 71335215602 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-2156-2) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-3 | 71335215603 | 21 TABLET, FILM COATED in 1 BOTTLE (71335-2156-3) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-4 | 71335215604 | 10 TABLET, FILM COATED in 1 BOTTLE (71335-2156-4) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-5 | 71335215605 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-2156-5) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-6 | 71335215606 | 40 TABLET, FILM COATED in 1 BOTTLE (71335-2156-6) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-7 | 71335215607 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-2156-7) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-8 | 71335215608 | 20 TABLET, FILM COATED in 1 BOTTLE (71335-2156-8) | 2022-08-22 | 0000-00-00 | No | No | Current |
| 71335-2156-9 | 71335215609 | 120 TABLET, FILM COATED in 1 BOTTLE (71335-2156-9) | 2022-08-22 | 0000-00-00 | No | No | Current |